MAIA Biotechnology Statistics
Share Statistics
MAIA Biotechnology has 29.59M
shares outstanding. The number of shares has increased by 19.79%
in one year.
| Shares Outstanding | 29.59M |
| Shares Change (YoY) | 19.79% |
| Shares Change (QoQ) | 3.26% |
| Owned by Institutions (%) | 5.79% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 576.57K, so 1.95% of the outstanding
shares have been sold short.
| Short Interest | 576.57K |
| Short % of Shares Out | 1.95% |
| Short % of Float | 2.24% |
| Short Ratio (days to cover) | 1.85 |
Valuation Ratios
The PE ratio is -1.89 and the forward
PE ratio is -2.92.
MAIA Biotechnology's PEG ratio is
0.06.
| PE Ratio | -1.89 |
| Forward PE | -2.92 |
| PS Ratio | 0 |
| Forward PS | 0.9 |
| PB Ratio | 12.09 |
| P/FCF Ratio | -2.8 |
| PEG Ratio | 0.06 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for MAIA Biotechnology.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.65,
with a Debt / Equity ratio of 0.
| Current Ratio | 2.65 |
| Quick Ratio | 2.65 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 297494.91 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,788,819.69 |
| Employee Count | 13 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -79.95K |
| Effective Tax Rate | 0.34% |
Stock Price Statistics
The stock price has increased by -34.42% in the
last 52 weeks. The beta is 0.24, so MAIA Biotechnology's
price volatility has been higher than the market average.
| Beta | 0.24 |
| 52-Week Price Change | -34.42% |
| 50-Day Moving Average | 1.74 |
| 200-Day Moving Average | 2.28 |
| Relative Strength Index (RSI) | 54.63 |
| Average Volume (20 Days) | 193,332 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.96M |
| Net Income | -23.25M |
| EBITDA | -16.96M |
| EBIT | -23.25M |
| Earnings Per Share (EPS) | -1.05 |
Full Income StatementBalance Sheet
The company has 9.6M in cash and 0 in
debt, giving a net cash position of 9.6M.
| Cash & Cash Equivalents | 9.6M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -87.23M |
| Total Assets | 10.16M |
| Working Capital | 6.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -15.7M
and capital expenditures 0, giving a free cash flow of -15.7M.
| Operating Cash Flow | -15.7M |
| Capital Expenditures | n/a |
| Free Cash Flow | -15.7M |
| FCF Per Share | -0.71 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
